Article metrics

Download PDFPDF
Real-world outcomes of abiraterone and enzalutamide in first-line treatment of metastatic castration-resistant prostate cancer: which patients benefit most?

 

Online download statistics by month:

Online download statistics by month: October 2021 to January 2024

AbstractFullPdf
Oct 20211661168
Nov 2021106113
Dec 202139723
Jan 202231763
Feb 202222142
Mar 202226100
Apr 202226900
May 202232862
Jun 202226020
Jul 202222831
Aug 202225830
Sep 202222061
Oct 202223720
Nov 202225750
Dec 202221820
Jan 202324500
Feb 202318331
Mar 202316711
Apr 202321000
May 202315200
Jun 202315211
Jul 202318720
Aug 202330973
Sep 202342355
Oct 202328488
Nov 202321252
Dec 202310811
Jan 202412701
Total89529146